Proteins and Peptides

12 Oct 2007 Two-year Phase IIIb data show that the new formulation of Rebif® offers a near three-fold improvement in injection tolerability and reduced immunogenicity
12 Oct 2007 Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure
12 Oct 2007 Affymax Doses First Patient in the Phase 3 Clinical Program of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients
12 Oct 2007 NascaCell Technologies AG and Boehringer Ingelheim sign collaboration agreement on therapeutic Microbodies(TM)
11 Oct 2007 Advitech Announces Positive Preclinical Results for Wound-Healing Application
11 Oct 2007 Biological Validation of Lead Compunds in Rheumatoid Arthritis Programme
09 Oct 2007 Jerini Initiates FDA Submission Process of New Drug Application for Icatibant in the Treatment of HAE
09 Oct 2007 Alnylam Presents First Ever Non-Human Primate Data with an RNAi Therapeutic Targeting PCSK9 Showing Significant and Durable Reductions in LDL Cholesterol Levels
06 Oct 2007 Interim Results from a New Trial of CANCIDAS(R) (caspofungin acetate) in Pediatric Patients with Documented Fungal Infections
06 Oct 2007 Genzyme Receives Approval to Market Elaprase(R) in Japan
05 Oct 2007 ThromboGenics and Rhein Minapharm Announce Agreement
04 Oct 2007 Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
04 Oct 2007 Roche and Trimeris Provide Update on Development of Alternative Administration Options for Delivery of FUZEON(R)
04 Oct 2007 MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
04 Oct 2007 Protox completes BPH trial recruitment and announces positive interim data
03 Oct 2007 Chemokine Therapeutics Completes Patient Recruitment of CTCE-9908 Phase I/II Clinical Trial
03 Oct 2007 CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial
02 Oct 2007 FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
02 Oct 2007 BioLineRx In-Licenses Novel Peptide BL-4050 for the Treatment of Cancer
02 Oct 2007 Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
28 Sep 2007 Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
28 Sep 2007 Nuvelo Announces Publication of NU206 Study Results in Proceedings of the National Academy of Sciences of the United States of America
28 Sep 2007 Palatin Technologies, Inc. Reports positive data from an at-home study of pre- and postmenopausal women with female sexual arousal disorder treated with bremelanotide
27 Sep 2007 Nycomed and NPS Pharmaceuticals Announce Licensing Agreement for GATTEX(TM)
27 Sep 2007 Phase 2 Study Suggests That Extended Dosing of Aranesp(R) is as Efficacious as Weekly Dosing

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top